| Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control T Robert, I De Mesmaeker, G Stangé, K Suenens, Z Ling, E Kroon, ... Stem Cell Reports 10 (3), 739-750, 2018 | 79 | 2018 |
| Heterogeneity in the beta-cell population: a guided search into its significance in pancreas and in implants D Pipeleers, I De Mesmaeker, T Robert, F Van Hulle Current diabetes reports 17, 1-7, 2017 | 31 | 2017 |
| Increase Functional β-Cell Mass in Subcutaneous Alginate Capsules With Porcine Prenatal Islet Cells but Loss With Human Adult Islet Cells. DP I De Mesmaeker, T Robert, K Suenens, G Stangé, F Van Hulle, Z Ling, P ... Diabetes 67 (12), 2640-2649, 2018 | 18 | 2018 |
| Cell Mass Increase Associated with Formation of Glucose‐Controlling β‐Cell Mass in Device‐Encapsulated Implants of hiPS‐Derived Pancreatic Endoderm T Robert, I De Mesmaeker, F Van Hulle, K Suenens, G Stangé, Z Ling, ... Stem Cells Translational Medicine, 2019 | 14 | 2019 |
| Concise review: markers for assessing human stem cell-derived implants as β-cell replacement in type 1 diabetes D Pipeleers, T Robert, I De Mesmaeker, Z Ling Stem Cells Translational Medicine 5 (10), 1338-1344, 2016 | 11 | 2016 |
Ines De MesmaekerVerified email at vub.be
Ines De MesmaekerVerified email at vub.be